Eli Lilly (LLY) PT Raised to $675 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Citi hikes Eli Lilly & Co. (LLY) price target on Incretin estimates
October 23, 2023 9:36 AM EDTCiti analyst Andrew Baum raised the Eli Lilly & Co. (NYSE: LLY) price target to $675 from $525, maintaining a Buy rating on the stock in a recent note to clients.
Baum told investors that the firm is increasing its price target for the pharmaceutical giant... More
